Biohaven Ltd (BHVN)
45.55
+0.36
(+0.80%)
USD |
NYSE |
Nov 22, 09:57
Biohaven Enterprise Value: 4.191B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.191B |
| November 20, 2024 | 4.357B |
| November 19, 2024 | 4.303B |
| November 18, 2024 | 4.213B |
| November 15, 2024 | 4.110B |
| November 14, 2024 | 4.542B |
| November 13, 2024 | 4.580B |
| November 12, 2024 | 4.714B |
| November 11, 2024 | 4.923B |
| November 08, 2024 | 5.028B |
| November 07, 2024 | 4.981B |
| November 06, 2024 | 5.046B |
| November 05, 2024 | 4.811B |
| November 04, 2024 | 4.673B |
| November 01, 2024 | 4.758B |
| October 31, 2024 | 4.645B |
| October 30, 2024 | 4.715B |
| October 29, 2024 | 4.765B |
| October 28, 2024 | 4.845B |
| October 25, 2024 | 4.955B |
| October 24, 2024 | 4.907B |
| October 23, 2024 | 4.946B |
| October 22, 2024 | 4.936B |
| October 21, 2024 | 4.804B |
| October 18, 2024 | 4.968B |
| Date | Value |
|---|---|
| October 17, 2024 | 4.834B |
| October 16, 2024 | 4.817B |
| October 15, 2024 | 4.740B |
| October 14, 2024 | 4.948B |
| October 11, 2024 | 5.045B |
| October 10, 2024 | 4.815B |
| October 09, 2024 | 4.797B |
| October 08, 2024 | 5.027B |
| October 07, 2024 | 4.946B |
| October 04, 2024 | 4.430B |
| October 03, 2024 | 4.331B |
| October 02, 2024 | 4.466B |
| October 01, 2024 | 4.230B |
| September 30, 2024 | 4.363B |
| September 27, 2024 | 4.385B |
| September 26, 2024 | 4.402B |
| September 25, 2024 | 4.217B |
| September 24, 2024 | 3.821B |
| September 23, 2024 | 3.906B |
| September 20, 2024 | 3.382B |
| September 19, 2024 | 3.384B |
| September 18, 2024 | 3.288B |
| September 17, 2024 | 3.250B |
| September 16, 2024 | 3.252B |
| September 13, 2024 | 3.163B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.64M
Minimum
Sep 29 2022
5.046B
Maximum
Nov 06 2024
2.116B
Average
1.971B
Median
Nov 09 2023
Enterprise Value Benchmarks
| Scholar Rock Holding Corp | 2.408B |
| Veru Inc | 72.33M |
| Regeneron Pharmaceuticals Inc | 74.00B |
| Vanda Pharmaceuticals Inc | -88.22M |
| Oramed Pharmaceuticals Inc | -50.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -160.30M |
| Total Expenses (Quarterly) | 178.17M |
| EPS Diluted (Quarterly) | -1.70 |
| Earnings Yield | -20.66% |